US House Committee concerned over IOJ&K situation – The News International

Posted on by

WASHINGTON: The US House Appropriations Committee has voiced its concern over the deteriorated human rights and religious freedom in India including in Indian-Occupied Jammu and Kashmir (IOJ&K) region.

In a detailed report, the committee highlighted that it was concerned over the deterioration of human rights and religious freedoms in India, including in IOJ&K, and the recent addition of religion as a factor in the naturalisation process.

The committee also directed the Secretary of State to submit a report, not later than 90 days after enactment of the Act, to the Committees on Appropriations on what steps the Department of State has taken to address the deterioration of human rights and religious freedom in India and a strategy to engage the government of India on these issues. "Such report shall also contain the extent to which the government of India is supporting human rights and implementing policies to protect freedom of expression, association, and religion, as well as due process of law," the committee said.

The report was submitted, accompanying a bill making appropriations for the Department of State, foreign operations, and related programs, for the fiscal year ending September 30, 2021, and for other purposes. The committee recommendation also included funding for Pakistan as well.

Meanwhile, the United States has also accepted Pakistan's accession to the 1980 Hague Convention on the Civil Aspects of International Child Abduction. The Convention will enter into force between the United States and Pakistan on October 1, 2020, and will put in place an internationally recognised legal framework to resolve cases of parental child abduction between the two countries. "As partners, both countries will enhance shared commitment to protecting children and open a new chapter in the vibrant US-Pakistan relationship," the State Department said adding, "Preventing and resolving cases of international parental child abduction is one of the Department's highest priorities."

The convention is a vital tool to deter international abduction and secure the return of abducted children. "It provides a mechanism under civil law in either country or parents seeking the return of children who have been wrongfully removed from or retained outside of their country of habitual residence in violation of custodial rights," the department said.

The US now has 80 partners under the Convention. "We look forward to welcoming Pakistan as a new partner in this global effort to address international parental child abduction," the department said.

Here is the original post:

US House Committee concerned over IOJ&K situation - The News International

I won 2 million playing poker – this is what I did next – Hull Live

Posted on by

He embraced the razzmatazz of Las Vegas and was renowned for his distinctive jacket and flamboyant nature.

When it came to winning Bridlington man John Hesp was a larger-than-life character even in the neon lights of Sin City.

But when it comes to spending cash he is a typical and humble Yorkshire man.

Mr Hesp became an overnight poker star after he stormed Las Vegas to win 2million, as the Daily Star reports.

The caravan salesman had only ever won a couple of hundred pounds at events at his local casino before his trip to Vegas in 2017.

But the granddad-of-eight left pokers top pros stunned when he finished in fourth out of 7,200 players in the World Series of Poker Main Event - the worlds biggest and most prestigious poker tournament.

Mr Hesp, 67, came away a millionaire having enjoyed the high life for a few weeks.

But back in East Yorkshire, you would be hard pushed to be persuaded about his incredible windfall.

There is no flashy car, no exotic holiday, only a trip to the Yorkshire Dales in his caravan with wife Mandy.

My lifestyle was never extravagant or exorbitant, Mr Hesp said, and to win the extra money, I could have more or less had anything. But I had everything.

When I say everything, I had my caravan in the Yorkshire Dales.

Mr Hesp has revealed the money he won in Vegas remains largely untouched.

We particularly enjoy the Dales for the peace and quiet that we get - and that was enough, he said.

We didnt need any fancy holidays or any big expensive toys or anything like that.

So the money is still in the bank!

We treated family, that sort of thing, so they had a few quid out of it but other than that, we havent really spent anything on ourselves.

This year, the World Series of Poker is taking place online only, and being hosted by GG Poker, due to the coronavirus pandemic.

At the tournament three years ago Hesp went from being an average man to an overnight poker superstar during and was even invited to dinner by the legendary Phil Hellmuth.

Video Unavailable

Click to playTap to play

Play now

Other poker superstars wanted selfies with him and Mr Hesp was known for his jovial table chatter and colourful jacket, which made him instantly recognisable anywhere in the poker room.

Simply by making the top thousand players, Hesp had achieved more than he could have ever imagined.

But when he got to the top 20, every elimination was suddenly worth a life-changing amount of cash.

And he insists his desire to have fun only worked in his favour.

How much did a $100,000 hike in prize money make to my style of play? I would say nothing, Hesp said. Whereas I think for most others, you would say that it did.

When I say nothing, I say that with a degree of humility. It is not intended to be cocky. But I had won when I got into the top thousand players. Anything else was a bonus.

I was determined to keep on playing just as I had been doing at the start with a spirit of fun and enjoyment in the game.

It was almost like I donned my jacket and my hat and became the fun face of poker.

In some way I would say it is a bit of an act, getting into a character mode. As we got towards the final table, it became symbolic of the fun side of it.

Such has been his remarkable tale, it is now in the process of being turned into a movie. Read more about that here.

But Mr Hesp has turned his back on pokers high life, happy to quit while he was very much ahead.

The extent of his poker playing is now restricted to private home games with his closest friends.

I was just a regular small town guy from Bridlington, who had a single buy-in to the biggest tournament in the world, Mr Hesp said.

In doing so, all these top pros that I only ever dreamed that I would ever meet, were actually wanting to rub shoulders with me and have pictures taken with me.

That experience alone was worth everything. The fact I won that money was wonderful.

"Take the money away and that experience alone was worth $10,000.

The rest is here:

I won 2 million playing poker - this is what I did next - Hull Live

Arjun Rampal is playing poker to support NGOs – The Hindu

Posted on by

Do you play poker? asks Arjun Rampal. No? Well, then we have to convert you, he laughs over a phone call from Mumbai.

Rampal is partner and brand ambassador for PokerHigh.com, a licensed poker site that is now aiming to raise funds for smaller, deserving charities in India.

There was a big surge in the number of people logging in to play [poker] during lockdown. We thought why not use this skilled game to give back to smaller NGOs that have not been getting recognition, he explains. There are different teams representing the charities and people can decide which one they wish to play for.

The initiative, which Rampal says has been successful, started two months ago when the group began sending food parcels to around two lakh people. This is our third month and we get players from all over India. The winners get to keep what they win. Whatever stake the bank makes goes to the NGOs, he says.

Other than Chennai-based Pudhiya Udhayam, there are also NGOs that serve animals such as CUPA in Bengaluru and Humanity for Animals in Kochi. Human life is important but so are the lives of animals, says Rampal, adding that during phase one they managed to generate 2.11 lakh, of which CUPA received a little over 72,000 (it took care of the feeding of over 150 dogs at the centre for a month) and Pudhiya Udhayam received 1.38 lakh, which took care of dry rations for over 500 families in Chennai.

The actor plays too, as a part of PokerHigh. My game is decent. But there is room for improvement, he laughs. Rampal has used time during lockdown to play a lot more poker. This time has been amazing as it allows you to introspect, pause and have a lot more clarity. Lot of things in life seem unnecessary and you can put them out of your list, he says.

The pandemic, Rampal believes, is a huge wake up call. We have to be far more compassionate and be open to change. Panicking is not going to help. It is important to adapt and adjust. We need to stick with the new norms, maintain social distance, wear a mask. A lot of people are just careless in the way they move around. If the pandemic has not shaken them up, then you should panic, he says.

Lockdown has also affected those in the film industry and although film shoots are yet to resume, Rampal says that it has altogether been a great year for him. I was working on three films and two web series.

This includes The Big Battle of Bhima Koregaon, Aparna Sens The Rapist, an unnamed action film he was shooting for in London, Abbas Mustans Penthouse. He was also set to start shooting for the second season of The Final Call. I was working 350 days of the year but God had other plans. He said go home and spend time with the family, and thats what I am doing with (partner) Gabriella [Demetriades], my daughters Mahikaa, Myra and my son Arik, he adds.

View original post here:

Arjun Rampal is playing poker to support NGOs - The Hindu

genetic engineering | Definition, Process, & Uses | Britannica

Posted on by

Genetic engineering, the artificial manipulation, modification, and recombination of DNA or other nucleic acid molecules in order to modify an organism or population of organisms.

Read More on This Topic

origins of agriculture: Genetic engineering

The application of genetics to agriculture since World War II has resulted in substantial increases in the production of many crops. This...

The term genetic engineering initially referred to various techniques used for the modification or manipulation of organisms through the processes of heredity and reproduction. As such, the term embraced both artificial selection and all the interventions of biomedical techniques, among them artificial insemination, in vitro fertilization (e.g., test-tube babies), cloning, and gene manipulation. In the latter part of the 20th century, however, the term came to refer more specifically to methods of recombinant DNA technology (or gene cloning), in which DNA molecules from two or more sources are combined either within cells or in vitro and are then inserted into host organisms in which they are able to propagate.

The possibility for recombinant DNA technology emerged with the discovery of restriction enzymes in 1968 by Swiss microbiologist Werner Arber. The following year American microbiologist Hamilton O. Smith purified so-called type II restriction enzymes, which were found to be essential to genetic engineering for their ability to cleave a specific site within the DNA (as opposed to type I restriction enzymes, which cleave DNA at random sites). Drawing on Smiths work, American molecular biologist Daniel Nathans helped advance the technique of DNA recombination in 197071 and demonstrated that type II enzymes could be useful in genetic studies. Genetic engineering based on recombination was pioneered in 1973 by American biochemists Stanley N. Cohen and Herbert W. Boyer, who were among the first to cut DNA into fragments, rejoin different fragments, and insert the new genes into E. coli bacteria, which then reproduced.

Most recombinant DNA technology involves the insertion of foreign genes into the plasmids of common laboratory strains of bacteria. Plasmids are small rings of DNA; they are not part of the bacteriums chromosome (the main repository of the organisms genetic information). Nonetheless, they are capable of directing protein synthesis, and, like chromosomal DNA, they are reproduced and passed on to the bacteriums progeny. Thus, by incorporating foreign DNA (for example, a mammalian gene) into a bacterium, researchers can obtain an almost limitless number of copies of the inserted gene. Furthermore, if the inserted gene is operative (i.e., if it directs protein synthesis), the modified bacterium will produce the protein specified by the foreign DNA.

A subsequent generation of genetic engineering techniques that emerged in the early 21st century centred on gene editing. Gene editing, based on a technology known as CRISPR-Cas9, allows researchers to customize a living organisms genetic sequence by making very specific changes to its DNA. Gene editing has a wide array of applications, being used for the genetic modification of crop plants and livestock and of laboratory model organisms (e.g., mice). The correction of genetic errors associated with disease in animals suggests that gene editing has potential applications in gene therapy for humans.

Genetic engineering has advanced the understanding of many theoretical and practical aspects of gene function and organization. Through recombinant DNA techniques, bacteria have been created that are capable of synthesizing human insulin, human growth hormone, alpha interferon, a hepatitis B vaccine, and other medically useful substances. Plants may be genetically adjusted to enable them to fix nitrogen, and genetic diseases can possibly be corrected by replacing dysfunctional genes with normally functioning genes. Nevertheless, special concern has been focused on such achievements for fear that they might result in the introduction of unfavourable and possibly dangerous traits into microorganisms that were previously free of theme.g., resistance to antibiotics, production of toxins, or a tendency to cause disease. Likewise, the application of gene editing in humans has raised ethical concerns, particularly regarding its potential use to alter traits such as intelligence and beauty.

In 1980 the new microorganisms created by recombinant DNA research were deemed patentable, and in 1986 the U.S. Department of Agriculture approved the sale of the first living genetically altered organisma virus, used as a pseudorabies vaccine, from which a single gene had been cut. Since then several hundred patents have been awarded for genetically altered bacteria and plants. Patents on genetically engineered and genetically modified organisms, particularly crops and other foods, however, were a contentious issue, and they remained so into the first part of the 21st century.

Originally posted here:

genetic engineering | Definition, Process, & Uses | Britannica

Viewpoint: Fish farming has a sustainability problem and genetic engineering might be the solution – Genetic Literacy Project

Posted on by

As the world endures the impacts of a rapidly changing climatesea level rise, extreme weather events, warming and acidifying oceans (among many others)policy makers and the public should critically examine how food production contributes to these worrying trends. Animal agriculture may be the best place to start since, many scientists argue, its the single biggest cause of biodiversity loss and a significant source of greenhouse gas emissions.

Over a quarter of the worlds land surface is currently dedicated to raising animals for food, but that practice can be exceptionally wasteful. Despite taking up almost 80 percent of global agricultural land, livestock represents less than 20 percent of the worlds calories. Proper stewardship of the land, which absorbs nearly one-third of global greenhouse gas emissions, is critical in our fight against climate change, but human activities degrade roughly a quarter of it, and livestock production is perhaps the primary culprit.

To help combat these growing environmental challenges, concerned citizens around the world are eating more sustainable and arguably healthier diets that partially or entirely replace meat with fish, crustaceans, and other aquatic animals. Fish production generally has a lower environmental impact than land animal farming, owing to the fact that fish require less feed. Most fish are poikilotherms, which means they dont use energy to heat their bodies. And unlike most land animals (homeotherms), fish dont need to constantly maintain their body temperatures, which tend to fluctuate with their external environment. Moreover, the density of water carries the weight of the fish, eliminating the requirement for heavy bones.

Despite its lower environmental footprint, global fish productionwhich includes wild capture and aquaculture (fish farming)has its own sustainability issues. Around one-third of the worlds marine fish stocks have reached unsustainable levels due to overfishing. Simultaneously, the global demand for fish and nutritional oils containing omega-3 fatty acids is increasing rapidly as more consumers recognize that consuming them is linked to reduced cardiovascular disease risk. Saturation in capture fishing since the early 1990s means aquaculture is filling consumer demand for fish. But without significant changes, aquaculture isnt a long-term solution.

Fortunately, a valuable but misunderstood tool can help the industry become more sustainable. Of course, Im talking about biotechnology. Genetic engineering has sped up the production of fish, and enabled the development of sustainable fish feed sources and nutritional oils. All three innovations are marching toward commercialization, and the evidence indicates their collective impact will be enormous.

While commercial fish farms have greatly improved their production systems over the years, feeding fish with fish (primarily fishmeal and oils) still poses a significant sustainability threat. In 2018, global fish production reached around 179 million tons, and humans ate about 88 percent of the produce (156 million tons) while about 10 percent (18 million tons) went towards producing fishmeal and fish oils. Finding alternative feed sources would slash the environmental footprint of aquaculture and contribute to global food security goals.

Breeding better fish

Fish maturity is based on physical features such as shape and size. The faster fish grow, the lower their environmental impact, so innovators have targeted faster growth rates as a solution to the industrys sustainability problem. In 2015, the Food and Drug Administration (FDA) approved a bioengineered Atlantic salmon for consumption after decades of rigorous scientific review. The FDA concluded that the genetically engineered AquAdvantage salmon is as safe to eat as any non-genetically engineered Atlantic, and also as nutritious. This salmon is approved for sale in Canada and is slated for commercialization in the US.

Scientists at the biotech firm AquaBounty introduced two different bits of genetic information from other fish species into a bioengineered salmon: a growth hormone gene from the fast-growing Chinook salmon controlled by a DNA switch (promoter) from the ocean pout. Because the Chinook growth hormone gene works overtime, AquaBountys salmon grows to full size in about half the time required by conventional salmonand consumes 25 percent less feed as a result.

Faster growth means the energy and carbon emissions required to produce the fish are lower. And since AquaBountys land-based aquaculture facilities are located in Canada and the US, transporting these fish to market generates lower carbon emission than delivering conventional salmon by air or ship. Additionally, the expansion of genetically engineered fish production could significantly reduce overfishing, since some of salmon feed comes from other wild fish.

Some environmentalists have voiced concerns about the consequences of bioengineered fish escaping into the wild. In theory, genetically engineered fish may flee to the wild, breed with their wild relatives and create a hybrid that could out-compete other fish in the marine ecosystem. Quite rightly, these are serious concerns that require proper attention and strong mitigation plans.

Considering the trade-off between hypothetical risks and the demonstrated benefits of biotechnology in fish production helps us evaluate the situation. AquAdvantage salmon are produced in land-based facilities and are sterile. Regulators at the FDA have therefore concluded its extremely unlikely that the fish could escape and establish themselves in the wild.

Shorter production time and lower feed and energy requirements clearly outweigh the low risk of fish escaping into the wild. And we get all these without compromising the nutritional value of the fish itself. AquaBounty is scheduled to begin producing its bioengineered salmon in the US before the end of 2020, making it the first genetically engineered food animal to hit US markets. As COVID-19 continues to put pressure on food supplies, the introduction of genetically engineered salmon helps illustrate how biotechnology can help solve critical problems.

Alternative fish feeds and fish oils

Bioengineered fish is an important step in the right direction, but it doesnt fully address aquacultures sustainability issues. The industry has developed non-fish based feeds, cutting use of fishmeal and fish oil from 30 million tons in 1994 to about 18 million tons in 2018. But there are concerns that fish products grown on alternative feeds arent providing the same nutritional value as those fed real fish, which is high in omega-3 oils. To understand why, we need to look at the chemistry of these fatty acids.

Omega-3 oils are long-chain polyunsaturated fatty acids existing mainly in three types: -linolenic acid (ALA); eicosapentaenoic acid (EPA); and docosahexaenoic acid (DHA). Plant oils contain ALA, which is the shorter version of EPA and DHA omega-3 fatty acids, typically found in marine organisms like microalgae and phytoplankton.

Our bodies cant make omega-3, so we mostly get it from eating fish, which incidentally also cant make omega-3 but accumulate it by eating microalgae and phytoplankton. As vegetable oils replace fish oil in aquafeeds, the level of beneficial fatty acids, EPA and DHA, have also declined considerably, reducing the nutritional value that fish offer. Therefore, the aquaculture industry needs to identify aquafeeds that are derived from alternative sources and provide the same level of nutrition.

Algae are a promising source to replace fish oil, but extracting algal oil is more expensive than producing fish oil and fishmeal, though the extraction technology is rapidly developing. Additionally, algae cultivation for aquafeed is sometimes limited to species that only produce DHA fatty acids, which means the algae-fed fish lack EPA, compromising their final nutritional value.

Again, scientists have turned to biotechnology to address this problem. Research teams have engineered plants like camelina and canola that contain high levels of EPA and DHA in their seed oil. These plants naturally produce the shorter version of omega-3, ALA, and scientists introduced microalgal genes that convert ALA into EPA and DHA omega-3 fatty acids typically found in fish. Research shows that fish fed with seed oil from these camelina plants show good growth, maintain feed efficiency and dont lose nutritional valueindicating that genetically engineered plants can provide a sustainable substitute for fish oil feeds.

Now innovators are aiming to produce omega-3 oils from camelina for aquafeeds and nutritional supplements. Biotech startup Yield10 Bioscience has fused artificial intelligence with synthetic biology to create a technology that identifies trait targets to produce better plants. Using their technology platform and genome editing, they have generated camelina plants that produce double seed yields with a high content of both EPA and DHA omega-3 oils. The company has recently launched field trials of their genome-edited seeds. They are scaling seed production, aiming to plant thousands of acres of camelina to produce plant-based omega-3 oil products for fish feed and human nutrition soon. Crucially, the USDA announced in January 2020 that it wont regulate gene-edited camelina, accelerating development of this sustainable omega-3 oil source.

Biotechnology is already accelerating production of environmentally friendly salmon, and is poised to provide more sustainable fish feed and nutritional oils in the coming years. It could also bring aquaculture production costs down, reducing incentives to overfish our oceans, which will no doubt be better for the marine ecosystem.

Surging fish demand will only be met by sustainable, low-cost solutions, enabled in key instances by biotechnology. Technical details aside, the benefits of broader biotechnology adoption in aquaculture will extend beyond the developed world to improve the lives of those most in needimpoverished people in the developing world.

Rupesh Paudyal holds a PhD in plant science and covers agriculture and the environment as a freelance writer. Visit his website and follow him on Twitter @TalkPlant

More here:

Viewpoint: Fish farming has a sustainability problem and genetic engineering might be the solution - Genetic Literacy Project

13 Important Genetic Engineering Pros And Cons | Bio Explorer

Posted on by

Over the last century, the field of genetics and biotechnology has greatly developed because of the better understanding of the gene. Because of the improvement of technology, scientists have already gone up until the manipulation of the genome (complete set of genes) of organisms. This process is called genetic engineering. In this article, we will explore 13 important genetic engineering pros and cons.

The sharing of genetic material among living organisms is known to be a natural event. This phenomenon is known to be very evident among bacteria, hence they are called natures own genetic engineer. Such phenomenon is the inspiration of scientists in this endeavor.

In literature, there are in fact many synonyms of the term genetic engineering: genetic modification, genome manipulation, genetic enhancement, and many more. However, this term shall not be confused with cloning because genetic engineering involves the production of new set of genes while the latter only involves the production of the same copies of genes in the organism.

Genetic engineering is the process of manipulating an organisms genome using biotechnology and the products of it are either referred to as genetically modified or transgenic organisms. Check out the disadvantages of genetically modified foods here.

Basically, genetic engineering is done by inserting a gene of interest from sources like bacteria, viruses, plants, and animals into the target organism. As a result, the organism with the inserted gene of interest is now able to carry out the new trait or characteristic.

This technology grants us the ability to overcome barriers, exchange genes among organisms, and produce new organisms with favorable traits.

For a more detailed explanation of the process, check out this video below:

Now we will dive into the pros and cons of Genetic Engineering now.

Supporters of genetic engineering believe that genetic engineering is indeed safe and is still comparable to the traditional process of breeding in plants and animals. Advocates of genetic engineering support the technology primarily because of the following reasons:

On the other hand, there are several types of potential health effects that could arise from the insertion of a novel gene into an organism. Critics disagree with the methods of genetic engineering because of:

Because of the technology used to create genetically modified crops and animals, private companies that produce them do not share their products at a reasonable cost with the public.

In addition, they believe that the process is somewhat disrupting the natural way and complexity of life. In addition to this, critics fear the misuse and abuse of biotechnology.

Indeed, genetic engineering will always have two opposite sides. While the possibilities of what science can create are endless, and the harmful effects also are. At present, it is important to know that the real risks and benefits of genetic engineering lie in how science is interpreted and used.

But theres really no doubt that with the rapid advancements in technology, the creation of GM organisms are also increasing.

What do you think? Are GM organisms slowly becoming the future?

See the article here:

13 Important Genetic Engineering Pros And Cons | Bio Explorer

Genetic Engineering – humans, body, used, process, plants …

Posted on by

Photo by: Gernot Krautberger

Genetic engineering is any process by which genetic material (the building blocks of heredity) is changed in such a way as to make possible the production of new substances or new functions. As an example, biologists have now learned how to transplant the gene that produces light in a firefly into tobacco plants. The function of that genethe production of lighthas been added to the normal list of functions of the tobacco plants.

Genetic engineering became possible only when scientists had discovered exactly what is a gene. Prior to the 1950s, the term gene was used to stand for a unit by which some genetic characteristic was transmitted from one generation to the next. Biologists talked about a "gene" for hair color, although they really had no idea as to what that gene was or what it looked like.

That situation changed dramatically in 1953. The English chemist Francis Crick (1916 ) and the American biologist James Watson (1928 ) determined a chemical explanation for a gene. Crick and Watson discovered the chemical structure for large, complex molecules that occur in the nuclei of all living cells, known as deoxyribonucleic acid (DNA).

DNA molecules, Crick and Watson announced, are very long chains or units made of a combination of a simple sugar and a phosphate group.

Amino acid: An organic compound from which proteins are made.

DNA (deoxyribonucleic acid): A large, complex chemical compound that makes up the core of a chromosome and whose segments consist of genes.

Gene: A segment of a DNA molecule that acts as a kind of code for the production of some specific protein. Genes carry instructions for the formation, functioning, and transmission of specific traits from one generation to another.

Gene splicing: The process by which genes are cut apart and put back together to provide them with some new function.

Genetic code: A set of nitrogen base combinations that act as a code for the production of certain amino acids.

Host cell: The cell into which a new gene is transplanted in genetic engineering.

Human gene therapy (HGT): The application of genetic engineering technology for the cure of genetic disorders.

Nitrogen base: An organic compound consisting of carbon, hydrogen, oxygen, and nitrogen arranged in a ring that plays an essential role in the structure of DNA molecules.

Plasmid: A circular form of DNA often used as a vector in genetic engineering.

Protein: Large molecules that are essential to the structure and functioning of all living cells.

Recombinant DNA research (rDNA research): Genetic engineering; a technique for adding new instructions to the DNA of a host cell by combining genes from two different sources.

Vector: An organism or chemical used to transport a gene into a new host cell.

Attached at regular positions along this chain are nitrogen bases. Nitrogen bases are chemical compounds in which carbon, hydrogen, oxygen, and nitrogen atoms are arranged in rings. Four nitrogen bases occur in DNA: adenine (A), cytosine (C), guanine (G), and thymine (T).

The way in which nitrogen bases are arranged along a DNA molecule represents a kind of genetic code for the cell in which the molecule occurs. For example, the sequence of nitrogen bases T-T-C tells a cell that it should make the amino acid known as lysine. The sequence C-C-G, on the other hand, instructs the cell to make the amino acid glycine.

A very long chain (tens of thousands of atoms long) of nitrogen bases tells a cell, therefore, what amino acids to make and in what sequence to arrange those amino acids. A very long chain of amino acids arranged in a particular sequence, however, is what we know of as a protein. The specific sequence of nitrogen bases, then, tells a cell what kind of protein it should be making.

Furthermore, the instructions stored in a DNA molecule can easily be passed on from generation to generation. When a cell divides (reproduces), the DNA within it also divides. Each DNA molecule separates into two identical parts. Each of the two parts then makes a copy of itself. Where once only one DNA molecule existed, now two identical copies of the molecule exist. That process is repeated over and over again, every time a cell divides.

This discovery gave a chemical meaning to the term gene. According to our current understanding, a specific arrangement of nitrogen bases forms a code, or set of instructions, for a cell to make a specific protein. The protein might be the protein needed to make red hair, blue eyes, or wrinkled skin (to simplify the possibilities). The sequence of bases, then, holds the code for some genetic trait.

The Crick-Watson discovery opened up unlimited possibilities for biologists. If genes are chemical compounds, then they can be manipulated just as any other kind of chemical compound can be manipulated. Since DNA molecules are very large and complex, the actual task of manipulation may be difficult. However, the principles involved in working with DNA molecule genes is no different than the research principles with which all chemists are familiar.

For example, chemists know how to cut molecules apart and put them back together again. When these procedures are used with DNA molecules, the process is known as gene splicing. Gene splicing is a process that takes place naturally all the time in cells. In the process of division or repair, cells routinely have to take genes apart, rearrange their components, and put them back together again.

Scientists have discovered that cells contain certain kinds of enzymes that take DNA molecules apart and put them back together again. Endonucleases, for example, are enzymes that cut a DNA molecule at some given location. Exonucleases are enzymes that remove one nitrogen base unit at a time. Ligases are enzymes that join two DNA segments together.

It should be obvious that enzymes such as these can be used by scientists as submicroscopic scissors and glue with which one or more DNA molecules can be cut apart, rearranged, and the put back together again.

Genetic engineering requires three elements: the gene to be transferred, a host cell into which the gene is inserted, and a vector to bring about the transfer. Suppose, for example, that one wishes to insert the gene for making insulin into a bacterial cell. Insulin is a naturally occurring protein made by cells in the pancreas in humans and other mammals. It controls the breakdown of complex carbohydrates in the blood to glucose. People whose bodies have lost the ability to make insulin become diabetic.

The first step in the genetic engineering procedure is to obtain a copy of the insulin gene. This copy can be obtained from a natural source

Phototake

(from the DNA in a pancreas, for example), or it can be manufactured in a laboratory.

The second step in the process is to insert the insulin gene into the vector. The term vector means any organism that will carry the gene from one place to another. The most common vector used in genetic engineering is a circular form of DNA known as a plasmid. Endonucleases are used to cut the plasmid molecule open at almost any point chosen by the scientist. Once the plasmid has been cut open, it is mixed with the insulin gene and a ligase enzyme. The goal is to make sure that the insulin gene attaches itself to the plasmid before the plasmid is reclosed.

The hybrid plasmid now contains the gene whose product (insulin) is desired. It can be inserted into the host cell, where it begins to function just like all the other genes that make up the cell. In this case, however, in addition to normal bacterial functions, the host cell also is producing insulin, as directed by the inserted gene.

Notice that the process described here involves nothing more in concept than taking DNA molecules apart and recombining them in a different arrangement. For that reason, the process also is referred to as recombinant DNA (rDNA) research.

The possible applications of genetic engineering are virtually limitless. For example, rDNA methods now enable scientists to produce a number of products that were previously available only in limited quantities. Until the 1980s, for example, the only source of insulin available to diabetics was from animals slaughtered for meat and other purposes. The supply was never large enough to provide a sufficient amount of affordable insulin for everyone who needed insulin. In 1982, however, the U.S. Food and Drug Administration approved insulin produced by genetically altered organisms, the first such product to become available.

Since 1982, the number of additional products produced by rDNA techniques has greatly expanded. Among these products are human growth hormone (for children whose growth is insufficient because of genetic problems), alpha interferon (for the treatment of diseases), interleukin-2 (for the treatment of cancer), factor VIII (needed by hemophiliacs for blood clotting), erythropoietin (for the treatment of anemia), tumor necrosis factor (for the treatment of tumors), and tissue plasminogen activator (used to dissolve blood clots).

Genetic engineering also promises a revolution in agriculture. Recombinant DNA techniques enable scientists to produce plants that are resistant to herbicides and freezing temperatures, that will take longer to ripen, and that will manufacture a resistance to pests, among other characteristics.

Today, scientists have tested more than two dozen kinds of plants engineered to have special properties such as these. As with other aspects of genetic engineering, however, these advances have been controversial. The development of herbicide-resistant plants, for example, means that farmers are likely to use still larger quantities of herbicides. This trend is not a particularly desirable one, according to some critics. How sure can we be, others ask, about the risk to the environment posed by the introduction of "unnatural," engineered plants?

The science and art of animal breeding also are likely to be revolutionized by genetic engineering. For example, scientists have discovered that a gene in domestic cows is responsible for the production of milk. Genetic engineering makes it possible to extract that gene from cows who produce large volumes of milk or to manufacture that gene in the laboratory. The gene can then be inserted into other cows whose milk production may increase by dramatic amounts because of the presence of the new gene.

One of the most exciting potential applications of genetic engineering involves the treatment of human genetic disorders. Medical scientists know of about 3,000 disorders that arise because of errors in an individual's DNA. Conditions such as sickle-cell anemia, Tay-Sachs disease, Duchenne muscular dystrophy, Huntington's chorea, cystic fibrosis, and Lesch-Nyhan syndrome result from the loss, mistaken insertion, or change of a single nitrogen base in a DNA molecule. Genetic engineering enables scientists to provide individuals lacking a particular gene with correct copies of that gene. If and when the correct gene begins functioning, the genetic disorder may be cured. This procedure is known as human gene therapy (HGT).

The first approved trials of HGT with human patients began in the 1980s. One of the most promising sets of experiments involved a condition known as severe combined immune deficiency (SCID). Individuals with SCID have no immune systems. Exposure to microorganisms that would be harmless to the vast majority of people will result in diseases that can cause death. Untreated infants born with SCID who are not kept in a sterile bubble become ill within months and die before their first birthday.

In 1990, a research team at the National Institutes of Health (NIH) attempted HGT on a four-year-old SCID patient. The patient received about one billion cells containing a genetically engineered copy of the gene that his body lacked. Another instance of HGT was a procedure, approved in 1993 by NIH, to introduce normal genes into the airways of cystic fibrosis patients. By the end of the 1990s, according to the NIH, more than 390 gene therapy studies had been initiated. These studies involved more than 4,000 people and more than a dozen medical conditions.

In 2000, doctors in France claimed they had used HGT to treat three babies who suffered from SCID. Just ten months after being treated, the babies exhibited normal immune systems. This marked the first time that HGT had unequivocally succeeded.

Controversy remains. Human gene therapy is the source of great controversy among scientists and nonscientists alike. Few individuals maintain that the HGT should not be used. If we could wipe out sickle cell anemia, most agree, we should certainly make the effort. But HGT raises other concerns. If scientists can cure genetic disorders, they can also design individuals in accordance with the cultural and intellectual fashions of the day. Will humans know when to say "enough" to the changes that can be made with HGT?

Photo Researchers, Inc.

Despite recent successes, most results in HGT since the first experiment was conducted in 1990 have been largely disappointing. And in 1999, research into HGT was dealt a blow when an eighteen-year-old from Tucson, Arizona, died in an experiment at the University of Pennsylvania. The young man, who suffered from a metabolic disorder, had volunteered for an experiment to test gene therapy for babies with a fatal form of that disease. Citing the spirit of this young man, researchers remain optimistic, vowing to continue work into the possible lifesaving opportunities offered by HGT.

The commercial potential of genetically engineered products was not lost on entrepreneurs in the 1970s. A few individuals believed that the impact of rDNA on American technology would be comparable to that of computers in the 1950s. In many cases, the first genetic engineering firms were founded by scientists involved in fundamental research. The American biologist Herbert Boyer, for example, teamed up with the venture capitalist Robert Swanson in 1976 to form Genentech (Genetic Engineering Technology). Other early firms like Cetus, Biogen, and Genex were formed similarly through the collaboration of scientists and businesspeople.

The structure of genetic engineering (biotechnology) firms has, in fact, long been a source of controversy. Many observers have questioned the right of a scientist to make a personal profit by running companies that benefit from research that had been carried out at publicly funded universities. The early 1990s saw the creation of formalized working relations between universities, individual researchers, and the corporations founded by these individuals. Despite these arrangements, however, many ethical issues remain unresolved.

Link:

Genetic Engineering - humans, body, used, process, plants ...

Dealing with New Biotechnology Realities in USMCA | AG – KMAland

Posted on by

(Washington, D.C.) -- When the original NAFTA agreement was implemented in 1994, biotechnology processes intended for practical agricultural use was in its early stages. But genetic modification has come a long way in the past quarter-century and advances continue daily.

Laboratory-based genetic sequencing and manipulation is clearly addressed in the new U.S.-Mexico-Canada trade agreement rules. So now, scientific processes and regulations that evolved independently for more than 25 years need to be standardized for the US, Mexico, and Canada.

Ian Affleck is Vice-President of Biotechnology for Crop Life Canada, with an agribusiness membership that includes seed companies and plant breeders. Crop Life Canada is working to align regulations spelled out under the new USMCA. And Affleck says those rules will require systemic changes because the American and the Canadian GMO development rules evolved very differently.

With the USMCA coming into force, theres a biotechnology chapter thats supposed to help the two countries align their approaches. Most countries around the world, the US included, chose a Process-based approach. So, their first step would be to say, Did you use genetic engineering, and create a GMO? If so, we want to take a look. Canada took a different approach, to say It doesnt matter how you made it, its really about what you made. Is the Product you made so new that we to take a look, as a government, to ensure its safety. We just start from a different foot to get to those approvals.

To say that genetic modification changed farming practices is an understatement. Glyphosate-tolerance, BT-insecticide integration, and trait-stacking made for huge and obvious changes to crops and yield. But Affleck says that recent advances in Gene Editing technology are far more subtle - and small differences can make big problems for seed-breeders accessing new markets.

The advent of gene editing is a really new technology for plant breeders. It adds a new wrinkle into the equation. With GMOs usually the changes were always big. With gene editing its not so certain. It may be able to make a larger or drastic change, or it might be a smaller change. So, this is why we need this policy guidance of what is new, to make sure that as plant breeders are embarking on products, they know what it is they have to do, to meet their regulatory expectations.

Crop Life Canada is lobbying in favor of the U.S. processed-based approach - for very practical reasons. Ian Affleck doesnt want Canadian farmers to miss out on American products.

The USDA-APHIS rules, if you were to boil them down its have you done something thats something that plant couldnt have done on its own, and if you did, youre going to need an assessment. If you didnt, you dont need an assessment. Thats a very rational way forward. If were not clear on our policies going forward, it could make launching US varieties in Canada a little more tricky.

Originally posted here:

Dealing with New Biotechnology Realities in USMCA | AG - KMAland

Genetic Engineering Industry Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025 – CueReport

Posted on by

The research report on Genetic Engineering Industry market provides a granular analysis of this industry vertical wherein notable market activities are thoroughly researched. Various market segmentations based on product type, application spectrum, and regional terrain are surveyed in-depth, while estimated share held by each segment by the end of forecast period is encompassed in the report.

The report also highlights the current remuneration of the market and offers an insight regarding the growth rate attained over the analysis timeframe. Vital parameters which will influence the market growth positively as well as negatively are enlisted. Further, the impact of COVID-19 pandemic outbreak on Genetic Engineering Industry market is also documented in the report.

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/20013

Citing the regional analysis:

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/20013

Additional insights from Genetic Engineering Industry market report:

Major Points Covered in TOC:

Overview:Along with a broad overview of the global Genetic Engineering Industry market, this section gives an overview of the report to give an idea about the nature and contents of the research study.

Analysis of Strategies of Leading Players:Market players can use this analysis to gain a competitive advantage over their competitors in the Genetic Engineering Industry market.

Study on Key Market Trends:This section of the report offers a deeper analysis of the latest and future trends of the market.

Market Forecasts:Buyers of the report will have access to accurate and validated estimates of the total market size in terms of value and volume. The report also provides consumption, production, sales, and other forecasts for the Genetic Engineering Industry market.

Regional Growth Analysis:All major regions and countries have been covered in the report. The regional analysis will help market players to tap into unexplored regional markets, prepare specific strategies for target regions, and compare the growth of all regional markets.

Segmental Analysis:The report provides accurate and reliable forecasts of the market share of important segments of the Genetic Engineering Industry market. Market participants can use this analysis to make strategic investments in key growth pockets of the market.

Key questions answered in the report:

Request Customization on This Report @ https://www.cuereport.com/request-for-customization/20013

Read the original post:

Genetic Engineering Industry Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025 - CueReport

Gene Editing Technologies in Diagnostic Platforms Market is expected to grow at a CAGR of 14.4% during the forecast period due to the rise in research…

Posted on by

There has been a rise in government funding and research programs which is paving the way for the growth of the gene editing technologies in diagnostic platforms market. For example, the National Institutes of Health (NIH) has allocated funding on the study of clustered regularly interspaced short palindromic repeats (CRISPR) from 2011 to 2018. The NIH spent about US$ 3,083.4 million between the fiscal year 2011 and 2018 on a total of 6,685 projects. The funding has been increased by 213.1% between the fiscal year 2014 and 2015.

Request for Sample Copy of This [emailprotected] https://www.absolutemarketsinsights.com/request_sample.php?id=477

Moreover, with the help of NIH Common Funds support, National Institutes of Health (NIH) launched Somatic Cell Genome Editing (SCGE) program on January 2018 which is working to improve the effectiveness and specificity of gene editing techniques to assist in the diminishing of the burden of common and erratic diseases caused by genetic variations. The program aims at developing quality tools to execute and determine effective and harmless genome editing in somatic cells of the body. These tools will be made extensively available to the research community to lessen the time and expense which is required to develop new therapies. Furthermore, Somatic Cell Genome Editing program will award approximately US$ 190 million to biomedical researchers over the six years starting from 2018 till 2023. Hence, these types of research programs and funding given to the researchers will help the diagnostic platforms to get the tools which will aid them in carrying out gene editing and will drive the future market of the gene editing technologies in diagnostic platforms.

The number of CRISPR related publications, as listed in the SCOPUS database of peer-reviewed research, shows the surge in funding. Between 2015 and 2016, the number of such publications raised 117.5% which is 1,457. In 2019, the number surpassed 3,900 and increased at a rate of 4.8%. Overall, 12,900 papers associated with the technique have been published since 2011, Thus, this increasing research is expected to assist in the gene editing technologies in diagnostic platforms market growth over the forecast period.

Enquiry Before Buying @ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=477

The detailed research study provides qualitative and quantitative analysis of gene editing technologies in diagnostic platforms market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Key Findings of the Report:

In terms of revenue, the gene editing technologies in diagnostic platforms market is expected to reach US$ 7,004.8 Mn by 2027, expanding at 14.4% CAGR during the forecast period due to the rising government funding for genome editing and engineering

Beam Therapeutics, Bio-Connect Group, CRISPR Therapeutics, Editas Medicine, GeneCopoeia, Inc., GenScript, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs, OriGene Technologies, Inc., Pairwise, Precision Biosciences, Sangamo Therapeutics, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., Transposagen Biopharmaceuticals, Inc. are the key market participants operating in the gene editing technologies in diagnostic platforms market.

Request for [emailprotected] https://www.absolutemarketsinsights.com/request_for_customization.php?id=477

Gene Editing Technologies in Diagnostic Platforms Market:

By Technology

CRISPR

TALEN

ZFN

Others

By Application

Cell Line Engineering

Genetic Engineering

Animal Genetic Engineering

Plant Genetic Engineering

Others

By End-User

Biotechnology & Pharmaceutical Companies

Academic and Research Institutions

Contract Research Organization (CROs)

By Geography

North America

U.S.

Canada

Mexico

Rest of North America

Europe

France

The UK

Spain

Germany

Italy

Nordic Countries

Denmark

Finland

Iceland

Sweden

Norway

Benelux Union

Belgium

The Netherlands

Luxembourg

Rest of Europe

Asia Pacific

China

Japan

India

New Zealand

Australia

South Korea

Southeast Asia

Indonesia

Thailand

Malaysia

Singapore

Rest of Southeast Asia

Rest of Asia Pacific

Middle East and Africa

Saudi Arabia

UAE

Egypt

Kuwait

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Get Full Information of this premium [emailprotected] https://www.absolutemarketsinsights.com/reports/Gene-Editing-Technologies-in-Diagnostic-Platforms-Market-2019-2027-477

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization.

From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Company: Absolute Markets Insights

Email id: [emailprotected]

Phone: +91-740-024-2424

Contact Name: Shreyas Tanna

The Work Lab,

The rest is here:

Gene Editing Technologies in Diagnostic Platforms Market is expected to grow at a CAGR of 14.4% during the forecast period due to the rise in research...

Biomedical Engineering Researcher Receives $5 Million Grant To Further Cancer Studies – Texas A&M University Today

Posted on by

A college of images of cells, each of which was collected from a 384 well plate using high throughput imaging.

Courtesy of Tanmay Lele

A new faculty member in the Department of Biomedical Engineering at Texas A&M University recently received a multi-million dollar grant to support groundbreaking cancer research.

In May, Tanmay Lele received a $5 million Recruitment of Established Investigators grant from the Cancer Prevention and Research Institute of Texas(CPRIT) to further knowledge about cancer and how it progresses.

Leles research focuses on mechanobiology the mechanical aspects of biology where he works to understand how cells sense external mechanical forces as well as how they generate mechanical forces, and how these mechanical forces impact cell function.

In cancer, both cellular mechanical forces and the mechanical properties of resisting cellular structures go awry. These errors cause abnormalities in cell structure. A particularly striking feature of cancer cells is the highly irregular and/or distended shape of the nucleus.

The nuclei in normal tissue have smooth surfaces, but over time the surfaces of cancer nuclei become irregular in shape, Lele said. Now, why? Nobody really knows. Were still at the tip of the iceberg at trying to figure this problem out. But nuclear abnormalities are ubiquitous and occur in all kinds of cancers breast, prostate and lung cancers.

Pathologists study biopsies and note abnormalities in the shape of the cell and its nucleus to grade the severity of cancer. Lele and his team are computerizing the analysis of nuclear shapes to research the cause of abnormal cancer structures.

Using photos of nuclei and cells in human tissue taken by a pathologist, Leles team has developed a computational algorithm to measure the degree of irregularity in the nucleus. With the algorithm, the team can run statistical analyses of the abnormalities and search for correlations between the extent of the irregularity, changes to genetic or molecular signatures in tumors and, ultimately, patient outcomes.

Leles research aims to help the medical community develop new knowledge of human cancers and how they progress, to better diagnose and manage cancers. Understanding the mechanisms behind the abnormalities can help develop therapies to better treat cancers by targeting the nucleus.

Like any other basic field, we are trying to make discoveries with the hope that they will have long-term impacts on human health, Lele said.

Lele will have two laboratories, one in College Station and one in the Texas A&M Health Science Centers Institute of Biosciences & Technology in Houston. The cancer grant from CPRIT is a collaborative effort with Dr. Michael Mancini and Dr. Fabio Stossi from the Baylor College of Medicine. He said he is looking forward to collaborating with researchers in both College Station and Houston.

Lele received his doctoral degree in chemical engineering from Purdue University. Before coming to Texas A&M, he served as the Charles A. Stokes Professor of Chemical Engineering at the University of Florida. At Texas A&M, in addition to being in biomedical engineering, he will be a joint faculty member in the Artie McFerrin Department of Chemical Engineering.

All my career has been spent in chemical engineering departments, but my research is also now in the biomedical space, Lele said. The move to Texas A&M was an opportunity for me to also be part of a different culture, if you will, of research. Being in the biomedical engineering department, in addition to the chemical engineering department, brings new opportunities to collaborate with researchers who have closely shared research interests.

Excerpt from:

Biomedical Engineering Researcher Receives $5 Million Grant To Further Cancer Studies - Texas A&M University Today

Future Prospects of Nucleic Acid Isolation and Purification Market Set to Witness Huge Growth by 2026 | Agilent Technologies, Bio-Rad Laboratories,…

Posted on by

Nucleic acid isolation and purification is an initial step in molecular biology studies and recombinant DNA techniques. The process of isolation includes mechanical and chemical disruption, enzymatic digestion, while the purification involves combination of extraction/precipitation, chromatography, centrifugation, electrophoresis, and affinity separation. This technique has wide applications in the field of genetic engineering, life science research, forensics and molecular diagnostics. Nucleic acid isolation helps in processing of more sample in less time, minimizes nucleic acid loss ad degradation and increases laboratory efficiency and effectiveness.

Get the PDF Sample Copy of This Report:

https://www.a2zmarketresearch.com/sample?reportId=86326

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in This Report:

Agilent Technologies, Bio-Rad Laboratories, F.Hoffmann-La-Roche, GE Healthcare, Thermo Fisher Scientific, Abcam, Bioline, Biotechrabbit, BioWORLD, Danaher, Epicentre, Hamilton, New England Biolabs, Omega Bio-tek, Promega, Qiagen, Sigma-Aldrich, Takara Bio

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Nucleic Acid Isolation and Purification market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Nucleic Acid Isolation and Purification markets trajectory between forecast periods.

Segmentation analyzation- To experience profitability and make critical decisions for business growth, it is very essential to understand this complex Nucleic Acid Isolation and Purification market. So to reduce this complexity, the Nucleic Acid Isolation and Purification market is divided into various segments.

Market Segmentation by Type:

DNA Isolation and PurificationRNA Isolation and Purification

Market Segmentation by Application:

HospitalResearchOthers

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=86326

Global Nucleic Acid Isolation and Purification Market report provide insights on following points:

Table of Contents

Global Nucleic Acid Isolation and Purification Market Research Report 2020 2026

Chapter 1 Nucleic Acid Isolation and Purification Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Nucleic Acid Isolation and Purification Market Forecast

If You Have Any Query, Ask Our Experts:

https://www.a2zmarketresearch.com/enquiry?reportId=86326

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

View original post here:

Future Prospects of Nucleic Acid Isolation and Purification Market Set to Witness Huge Growth by 2026 | Agilent Technologies, Bio-Rad Laboratories,...

Chromatography Resins Market 2020: Global Industry Analysis, Size, Share, Trends and Forecast by 2026 | GE Healthcare, Merck KGaA, Pall Corporation -…

Posted on by

The latest published report on Global Chromatography Resins Market Analysis and Forecast from 2019 to 2026 delivering key insights and providing a competitive advantage to clients through a detailed report. Additionally, the report focuses on Chromatography Resins industry key players, to define and analyze the sales volume, value, market share, market competitive landscape, and recent developments.

Global Chromatography resins market is estimated to reach $3.61 Billion by 2026; growing at a CAGR of 3.58% from 2019 to 2026.

Get The Sample Report PDF with Detail TOC & List of[emailprotected]https://marketresearchport.com/request-sample/46592

About Global Chromatography Resins Market

Firstly, the report offers a basic overview of the industry including, definitions, classifications, applications, and industry chain scenario. The Chromatography Resins industry analysis is provided for the global market including development history, segment analysis, major regional developments, and a thorough competitors evaluation.

Secondly, growth policies and plans are reviewed as well as manufacturing processes and cost structures. This report also discusses supply and consumption figures, import/export data, cost, price, revenue and gross margins by prime regions such as the U.S. Europe, China, and Japan along with other key regions. Moreover, Global Chromatography Resins Market proposes market trend analysis, drivers, and challenges by consumer behavior, and various marketing channels.

Competitive Glimpse

Top listed manufacturers for Global Global Chromatography Resins Market are:

Avantor Performance Materials Inc.Bio-Rad LaboratoriesGE HealthcareMerck KGaAMitsubishi Chemical CorporationPall CorporationPurolite CorporationRepligen CorporationThermo Fisher Scientific Inc.

With the slowdown in world economic growth, the Chromatography Resins industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years.

How has the competitive landscape of this industry been categorized?

The competitive scope of Global Chromatography Resins Market spans firms listed above, as per the report.The report includes substantial information pertaining to the produced goods, company profile, revenue graph, as well as other production patterns.The research study also presents details with respect to the market share that every company accounts for, as well as gross margins and price prototypes of the products.

Market Segmentation:

Esticast Research offers a crystal clear view of the various sections such as segmental analysis, regional analyst, product portfolios, followed by detailed information about market leaders and their strategies about mergers and acquisitions.

By Type

Natural polymerSynthetic polymerInorganic media

By Technique

Ion exchangeAffinitySize ExclusionHydrophobic InteractionMultimodalOthersBy Application

Pharmaceutical & biotechnologyFood & beverageWater and environmental analysisOthers (genetic engineering, diagnostics, and biochemistry)

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North AmericaEuropeAsia-PacificSouth AmericaThe Middle East and Africa

Do Enquiry For Customized Report as per Your[emailprotected]https://marketresearchport.com/enquiry-before-buying/46592

Major Points From TOC:Market IntroductionResearch MethodologyChromatography Resins Market OverviewType OverviewTechnique OverviewApplication OverviewChromatography Resins Market Regional OverviewCompany Profiles

About Us:Market Research Portis one of the best report resellers in the market bringing to you accurate and trustworthy market research reports by reputed publishers. Our trusted publishers have compiled their reports and findings after painstaking research and studies, set up against varied business parameters. Each report is detailed and then vetted for accuracy by industry experts. In each report, you will find deep analysis, risk analysis, market forecasts, emerging trends, different market segments, technological advancement and its impact, and a multitude of economic factors, giving you the most comprehensive market research report. You get many advantages with such comprehensive reports.

Contact Us:Market Research Port,Brighton Street, Providence,Rhode Island 02929, United StatesContact No: +1 401 433 7610Email:[emailprotected]Website:https://marketresearchport.com/

Excerpt from:

Chromatography Resins Market 2020: Global Industry Analysis, Size, Share, Trends and Forecast by 2026 | GE Healthcare, Merck KGaA, Pall Corporation -...

Why Is It So Hard to Adapt Brave New World? – The Ringer

Posted on by

In the back half of the 1970s, when miniseries adaptations like Rich Man, Poor Man and Roots became runaway hits, a great book could make or break a TV careerso the influential NBC producer Deanne Barkley scooped up as many great books as she could. By 1978, shed locked down the rights to James Micheners Centennial, recruited Natalie Wood for a six-part adaptation of From Here to Eternity, and picked up James Clavells Shogun for a lavish production destined to become a ratings sensation in 1980. And perhaps inspired by the Star Warsstoked interest in all things science fiction, she also commissioned an adaptation of Aldous Huxleys 1932 dystopian landmark Brave New Worlddespite it being, as a profile of Barkley described at the time, a tricky property everyone in Hollywood had been afraid of. Starring 2001: A Space Odysseys Keir Dullea and Harold and Maudes Bud Cort, it was set to debut in 1979 and run for six hours across several nights. Only it never did. NBC found out that adapting Brave New World was tricky indeedand not for the last time.

After pulling Brave New World from its schedule several times, NBC finally aired it in March 1980. A version of it, anywaythe miniseries had shrunk from six, to four, then finally three hours and been reduced to a TV movie. (What would have been the four-hour version, running just over three hours without commercials, eventually aired on BBC and is now the easiest cut to find.) The network returned to Huxleys World State again in 1998, with a TV movie starring Peter Gallagher and Leonard Nimoy. Then, for a few years in the late 00s, Brave New World seemed likely to become a feature film starring Leonardo DiCaprio and directed by Ridley Scott. Instead, its coming to us once again as an ongoing series, one of the flagships of Peacock, NBCs new streaming service (though this Brave New World was developed first for Syfy then for USA before finding its current home). A glossy take on the material filled with TV-MA-friendly amounts of explosive violence and tightly choreographed orgies, it proves that Huxleys book can be easily mined for concepts and incidents. Adapting it, on the other hand, proves far trickier.

Thats partly because much of the novel is short on incident and long on ideas, effectively climaxing with one character arguing why the dystopia of New London, however awful in its implications, makes sense as the only recourse against humanitys excesses. Which speaks to the books other tricky element: Brave New Worlds 600-years-in-the-future societyone thats banned monogamy and family, done its best to erase history, mandates the use the euphoria-inducing drug Soma, and uses a combination of genetic engineering and brainwashing to create a rigid caste systemis quite functional, maybe even desirable. After all, war has been eliminated. And whats the difference between drug-induced happiness and the real thing when you get down to it (to say nothing of all that attachment- and consequence-free sex)? On the one hand, Huxleys World State takes some worrisome tendencies from the years of its creation to their logical, if nightmarish, extremes, combining the most dehumanizing elements of communism and capitalism in a culture that despises individualism, places all control in the hands of the state, and reveres Henry Ford for inventing the assembly line and Sigmund Freud for demystifying the soul (even though it sometimes confuses the two men). On the other, it has a certain undeniable appeal.

Much of the power of Brave New World comes from just that tension. It often reads like a novel at war with itself, in part because it was written by a man occasionally at war with himself. The product of Eton and Oxford, Huxley had more faith in the elites than the masses, whom he estimated to make up 99.5 percent of the population, and enthused about the potential of eugenics (with some reservations). Like the books New Londoners, Huxley had little use for monogamy (though he and his first wife Maria incorporated that into a by-all-accounts successful marriage). While Brave New World sounds like a caution against all these feelings, they were hardly alien to its author, and Huxleys ability to convey their allure helps make the book so haunting.

Its a funny book, too, less a break from Huxleys earlier satiric writing than an extension of it. But each adaptation of Brave New World has struggled to convey that. The 1980 version comes closest simply because it hews closest to the source materialat times painfully close, dedicating its first act to backstory Huxley takes care of in a few paragraphs. Helmed by actor-turned-journeyman director Burt Brinckerhoff, its set in a white-surface- and jumpsuit-filled future that makes Logans Run look tasteful by comparison. It also makes Logans Run, whose hedonistic vision borrows heavily from Brave New World, look lively, trudging along from plot point to plot point while attempting to provoke yucks by supplementing Huxleys habit of giving his characters surnames like Marx and Bonaparte with characters named Bowie and Jagger. Only Cort, playing an oddball in a society with no tolerance for oddballs, and Superfly star Ron ONeal, as the erudite and unapologetic enforcer of the World Orders strictures, seem to have much of a take on the material.

Brinckerhoffs strict adherence to Huxleys novel extends to its depictions of the Savage Lands, an untamed, impoverished portion of the American Southwest with a culture that adheres to the old ways, mixing Christianity and Native American beliefs. Its not a happy place, but at least its free in ways that surprise John, a New Londoner raised in the Savage Lands, when hes taken back to civilization. In the 1998 adaptation codirected by Leslie Libman and Larry Williams, the Savage Lands are populated by Gen Xinspired no-goodniks who look like they stepped out of a Surge commercial, all decked out in baggy pants and stocking caps. (This fact, a rave scene, a scratch-heavy score, a featured Portishead song, and some distressed fonts make it a vision of a future dystopia deeply rooted in the late-1990s.) It takes other considerable liberties with Huxleys novel as well, including an out-of-nowhere happy ending at odds with the sources deeply pessimistic finale, one that suggests that the World State might represent some kind of end point from which humanity can never escape except via exile or death (unless, this version suggests, youre Peter Gallagher).

In 2008, it seemed likely both these already largely forgotten stabs at updating Huxley would become footnotes thanks to Ridley Scott. After all, who better to bring one of the defining literary utopias to life than the filmmaker who, with Blade Runner, created one of the defining cinematic utopias? Without naming the title, Scott enthused to an interviewer that hed waited for a book for 20 years and had finally secured the rights to it. That same year, the Los Angeles Times revealed the book to be Brave New World, a film that would star Leonardo DiCaprio, be produced by his father George DiCaprio, and be written by Andrew Niccol, writer of the Brave New Worldindebted Gattaca. When talk of the project stirred again in 2009, Niccol was out and Apocalypto screenwriter Farhad Safinia was in. Three years later, everyone seemed to have moved on. While insisting the film remained a possibility, Scott sounded resigned in an interview with Collider, saying I think Brave New World, in a funny kind of way, was good in [1932], because it had a very interesting revolutionary idea. When you reanalyze it, maybe it should stay as a book. I dont know. We tried to get it.

Whatever kept them from getting it, the Scott/DiCaprio Brave New World remains one of the big what-ifs of both their careers (even more so than the other project Scott was developing around his time: an adaptation of Monopoly). That doesnt mean it wouldve worked, or that the issues that dogged previous attempts to adapt it wouldnt have resurfaced. Would Scott have the clout he didnt have with Blade Runner in 1982 to keep its pessimistic ending? Would Leo have chosen this sci-fi blockbuster over the Christopher Nolan one he ended up going with? Would there have been too much money at stake not to turn it into a tale of resistance, like the many other early-2010s dystopias it would have appeared alongside, from The Hunger Games to the never-completed Divergent series?

That appears to be the direction in which Peacocks Brave New World is heading, however slowly. Developed by Brian Taylor (Crank, Mom and Dad), David Wiener (Homecoming), and comics great Grant Morrison, the series updates Huxleys world while somehow making it feel less relevant. In spite of smart touches like a privacy-erasing contact lens that feels like a direct descendant of Instagram and a Savage Lands that caricatures 21st-century working-class lifeas well as nice moments like John the Savage (Alden Ehrenreich) getting awakened to a richer, wider world by discovering a Radiohead songit plays less like an adaptation of Huxleys novel than an extremely watchable dilution, with little of the ambiguity that makes the novel so disturbing. Its New London society is so stuffed with obvious villains that of course it has to come crumbling down (however fun its pansexual dance-floor orgies might look).

But maybe a dilution is the best we can hope for. Or maybe the novel works best as a set of building blocks. Beyond Gattaca and Logans Run, Brave New World inspired Kurt Vonneguts Player Piano, George Lucass THX 1138, and other works (to say nothing of one of the Buzzcocks best songs). Or perhaps its just one of those books best left to work its disquieting spell on the page. Writing of it appreciatively on its 75th anniversary, Margaret Atwood, no stranger to disturbing visions of the future, contrasted it to George Orwells 1984, which she describes as a horrific vision of a brutal, mind-controlling totalitarian state. Orwells world might be tough to prevent, but its easy to spot; were in the midst of a presidential administration thats used its power to batter away at the very idea of truth in plain sight.

Huxleys softer totalitarianism is more insidious, and more seductive. It takes the form of pleasure and safety and a willingness to abdicate responsibility and individuality to maintain the status quo, no matter who gets reduced to a figure in an equation in the process. Brave New World is either a perfect-world utopia or its nasty opposite, a dystopia, depending on your point of view, Atwood continues. Its inhabitants are beautiful, secure, and free from diseases and worries, though in a way we like to think we would find unacceptable. For an adaptation of Brave New World to stay true to its origins, it would have to capture the difficulty of saying no to a too-good-to-be-true world always waiting to become reality. So far, no creator has been able to do that.

See the rest here:

Why Is It So Hard to Adapt Brave New World? - The Ringer

The Case For COVID-19 Antibody Therapies – The ASEAN Post

Posted on by

As many countries progressively relax their COVID-19 containment measures, preventing a renewed spread of the coronavirus from emerging infection clusters will be key to controlling the pandemic. And this will require the world to develop innovative new treatments.

So far, policymakers have relied on non-pharmaceutical interventions such as testing, contact tracing, and quarantines to prevent a second wave of infections. Meanwhile, the search for COVID-19 therapies and prophylactic medicines has focused on products that could be immediately available, meaning existing drugs that were developed to treat other conditions.

This approach has been largely unsuccessful, although a recent randomised clinical trial in the United Kingdom (UK) revealed that the dexamethasone corticosteroid reduced COVID-19 mortality in the most severe cases.

Vaccines will of course be essential to overcoming COVID-19. But if and when they become available, it will still take many months to vaccinate enough people so that societies reach the level of collective immunity needed to halt the coronavirus. And the efficiency of any vaccine will likely vary depending on a persons genetic background, associated diseases, and age.

Furthermore, vaccine access and coverage might be limited by production capabilities, economic considerations, and anti-vaccine sentiment among the population.

That means we must also focus on developing new weapons that can directly target SARS-CoV-2, the virus that causes COVID-19. And, besides anti-viral chemical drugs, genetically engineered antibodies might be ideal for this purpose.

Such antibodies are precisely tailored to neutralise the proteins that allow the SARS-CoV-2 virus to penetrate human cells. Moreover, they provide immediate immunity, which is critical not only to minimise organ damage but also to protect health-care professionals and the infected persons contacts.

The concept behind this type of immunotherapy was pioneered in France and Germany more than a century ago, when antibodies contained in the serum of immunised animals saved the lives of thousands of children during diphtheria epidemics. The same principle lies behind the current clinical trials using plasma from recovering COVID-19 patients. But because not all antibodies are protective indeed, some can even aggravate disease researchers are focusing on those known for their anti-viral activity.

Contemporary genetic engineering can produce highly specific humanised antibodies. Although these biological agents are best known for revolutionising the treatment of cancer and autoimmune diseases, there is already evidence of their efficacy as anti-infectious agents.

For example, the palivizumab antibody is used to prevent respiratory syncytial virus infections in infants, while other antibodies have been found to prevent or treat anthrax. And another has proven effective in helping HIV-infected people who are resistant to standard treatments. Most recently and relevantly, a cocktail of antibodies soon to be approved by the United States (US) Food and Drug Administration (FDA) was found to reduce Ebola mortality among patients.

Regeneron Pharmaceuticals, the US biotechnology firm that produced the Ebola antibodies, is now using its proprietary technology to develop a cocktail of two COVID-19 antibodies that are currently being tested in human trials. On 7 July, Regeneron Pharmaceuticals announced that it had received a US$450 million contract to manufacture and supply the antibody cocktail as part of the Biomedical Advanced Research and Development Authoritys (BARDA) Operation Warp Speed.

Several other companies are developing antibodies with the help of US government funding via the Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership. This initiative involves BARDA, the National Institutes of Health, the FDA, and the US Department of Defense, together with major pharmaceutical firms and philanthropic organisations such as the Bill & Melinda Gates Foundation.

Unfortunately, antibody therapies are currently receiving less attention in the European Commissions Coronavirus Global Response. This effort, which the Commission developed in collaboration with other governmental, corporate, and philanthropic organisations, aims to support the Access to COVID-19 Tools (ACT) Accelerator that the World Health Organization (WHO) and other global partners launched in April.

But the Economist Intelligence Unit reports that the COVID-19 Therapeutics Accelerator, a co-convenor of the ACT initiative, had so far invested only US$59 million, mostly in clinical trials exploring the potential benefits of repurposed drugs.

Several challenges still need to be addressed before genetically engineered antibodies can join the fight against COVID-19. These include increasing the antibodies stability in vivo to optimise the number of doses required, and decreasing manufacturing costs in order to make the therapy economically viable.

Funding organisations must now invest more resources to overcome these remaining hurdles. The rewards are potentially huge: antibody treatments that not only rapidly control viral replication in COVID-19 patients, but possibly also prevent vulnerable individuals from contracting the disease.

Related Article:

Are We Any Closer To A COVID-19 Vaccine?

Has A Secretive Institute Found A COVID-19 Cure?

Link:

The Case For COVID-19 Antibody Therapies - The ASEAN Post

What’s Trending in Aerospace – July 12, 2020 – Aviation Today

Posted on by

Check out the July 12 edition of What's Trending in Aerospace, where editors and contributors for Avionics Internationalbring you some of the top headlines and stories across various segments of the global aerospace industry that you should be aware of for the week ahead.

An x-ray rendering of XB-1, Boom's supersonic demonstrator aircraft, which is scheduled for rollout in October followed by a first flight in 2021. Photo: Boom Supersonic

Boom Supersonic's XB-1 subsonic demonstrator aircraft will roll out the companys Denver, Colorado hangar onOctober 7, the company said in a July 8 press release.

Due to COVID-19 social distancing recommendations, Boom plans on holding a virtual online unveiling of the XB-1. During the rollout event, Booms lead engineers, test pilots and company leadership will discuss the design, flight and handling criteria for XB-1.

The rollout is a key milestone toward its first flight expected to occur in 2021 to demonstrate key technologies, such as advanced carbon fiber composite construction, computer-optimized high-efficiency aerodynamics, and an efficient supersonic propulsion system.

Our experiences in the COVID-19 pandemic underscore for all of us the fundamental human need for personal connection. Faster travel enables us to experience the worlds people, cultures, and places, and XB-1 is the first step in bringing supersonic back to the world, said Blake Scholl, Boom founder and CEO. With XB-1, were demonstrating that we are prepared to bring back supersonic.

Honeywell Aerospace has received an Federal Aviation Administration Technical Standard Order (TSO) for its IntuVue RDR-7000 radar system, which the company first introduce at the 2019 NBAA Business Aviation Convention & Exhibition (NBAA-BACE).

The 3D radar is described by Honeywell as being fully automated, scanning from zero up to 60,000 feet, and up to 320 nautical miles in front of the aircraft.

Larger business and passenger jets have benefitted from IntuVue for years, and soon those same capabilities will be available on many more platforms, said Mike Ingram, vice president, Avionics, Honeywell Aerospace. Pilots of these smaller aircraft will have the same 3D capabilities, full automation and predictive weather insights to help them make critical decisions to navigate weather ahead of and around the aircraft.

Bombardiers Global 5000, Dassault Falcons 900C/EX/LX and Cessnas Citation X are among the aircraft RDR-7000 is currently available on, with initial delivers expected to begin in the third quarter.

Gogo has introduced new software configuration changes to its in-flight connectivity network that will enable pilots and passengers to connect at 3,000 feet above ground level (AGL) in place of the previous 10,000 feet AGL access point.

An additional 15 to 20 minutes of connectivity can be expected on most flights, a benefit to operators of shorter regional flights.

"The additional connectivity time is a significant enhancement and will deliver even more value to customers," said Sergio Aguirre, president of Gogo Business Aviation. "It makes connectivity available to those who believed inflight Wi-Fi wasn't an option because they fly shorter routes.

Availability at 3,000 feet will begin within a phased process to enable service through ground-system configuration and remote software updates, Gogo said in a statement. Approximately 1,300 AVANCE systems flying in business aviation will benefit from this change, as will roughly 650, commercial airline regional jets equipped with Gogo connectivity.

The United Kingdom is set to take a significant equity share inOneWebin a groundbreaking deal. On Friday, July 3, OneWeb announced the U.K. government through the Secretary of State for Business, Energy and Industrial Strategy will acquire the company by providing $500 million, withBharti Global Limitedproviding another $500 million.

The deal is still subject to regulatory approval and is expected to close by the fourth quarter of 2020.

OneWeb said it plans to continue building its communications system to deliver connectivity to remote and rural parts of the world, starting with the Arctic. The company, which has 74 satellites in Low-Earth Orbit (LEO),filed for Chapter 11 bankruptcyon March 27.

Read more about the investment and space industry reaction in Via Satellite.

The government of New South Wales, Australia, awarded a $700,000 grant AMSL Aero to support development of a four-seat electric vertical takeoff and landing aircraft.

The project, in development for a few years, relies on battery storage but plains to incorporate hydrogen fuel cells when that technology is more mature. Andrew Moore, chief executive of AMSL Aero, describes his goal as to provide low-cost, zero emissions transport to better connect Australian cities such as Sydney and Canberra a distance of 155 miles.

Government funds will be used to establish a testing facility and conduct test flights in the region of Narromine. The facility will be built in the next six to 12 months.

The FAA awarded $1.6 million to a group of five companies to develop and test a Contingency Management Platform intended to further fault detection and risk mitigation efforts for unmanned traffic management (UTM) systems. The team will test the platform at the New York UAS Test Site at Griffiss International Airport in collaboration with Northeast UAS Airspace Integration Research (NUAIR) and Oneida County.

The core health and usage monitoring and fault mitigation software will be provided by Syracuse, NY-based ResilienX, incorporating a TRL-9 cybersecurity module provided by Assured Information Security (AIS), micro-weather services from TruWeather, and beyond visual line of sight (BVLOS) airspace visualization and display information from Kongsberg Geospatial. Systems integration will be led by Beavercreek, OH-based CAL Analytics.

Link:

What's Trending in Aerospace - July 12, 2020 - Aviation Today

Aerospace Industry Semi-Finished Composite Materials Market Report, History and Forecast 2019-2023, Breakdown Data by Manufacturers, Key Regions,…

Posted on by

Study on the Global Aerospace Industry Semi-Finished Composite Materials Market

The report on the global Aerospace Industry Semi-Finished Composite Materials market reveals that the Aerospace Industry Semi-Finished Composite Materials market is anticipated to grow at a CAGR of ~XX% during the forecast period (2019-2029). The report provides a thorough assessment of the current and future prospects of the Aerospace Industry Semi-Finished Composite Materials market across various geographies. Further, the report provides accurate data related to the growth strategies adopted by leading market players operating in the Aerospace Industry Semi-Finished Composite Materials market.

The quantitative and qualitative assessment of the various segments of the Aerospace Industry Semi-Finished Composite Materials market enables stakeholders, investors, upcoming and established market players to devise robust business development strategies and expand their business. The report tracks the recent developments within the Aerospace Industry Semi-Finished Composite Materials market in terms of innovation, technological progress, regulatory framework, and more.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2697344&source=atm

Major Doubts Pertaining to the Aerospace Industry Semi-Finished Composite Materials Market Addressed in the Report

Segmentation Analysis of the Aerospace Industry Semi-Finished Composite Materials Market

The growth potential of the Aerospace Industry Semi-Finished Composite Materials market in each region is accurately depicted in the report. The market attractiveness index included in the report enables readers to identify the most lucrative pockets within the Aerospace Industry Semi-Finished Composite Materials market and make informed business decisions.

The report throws light on the adoption pattern of different products along with a thorough analysis of the pricing and supply-demand ratio of each product.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2697344&source=atm

Competitive Landscape

The competitive landscape section of the report tracks the business proceedings of the key players operating in the Aerospace Industry Semi-Finished Composite Materials market. The pricing, marketing, sales, and promotional strategies adopted by each market player is represented in the report.

Segment by Type, the Aerospace Industry Semi-Finished Composite Materials market is segmented intoFiberglassCarbon FiberOthers

Segment by Application, the Aerospace Industry Semi-Finished Composite Materials market is segmented intoAircraftGuided MissilesSpace VehiclesOthers

Regional and Country-level AnalysisThe Aerospace Industry Semi-Finished Composite Materials market is analysed and market size information is provided by regions (countries).The key regions covered in the Aerospace Industry Semi-Finished Composite Materials market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and Aerospace Industry Semi-Finished Composite Materials Market Share AnalysisAerospace Industry Semi-Finished Composite Materials market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Aerospace Industry Semi-Finished Composite Materials business, the date to enter into the Aerospace Industry Semi-Finished Composite Materials market, Aerospace Industry Semi-Finished Composite Materials product introduction, recent developments, etc.The major vendors covered:AVS-SYSMARKTECH P-D INTERGLAS TECHNOLOGIESTenCate Advanced CompositesTufnol CompositesXENIAARKEMA

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2697344&licType=S&source=atm

Key Findings of the Report

See original here:

Aerospace Industry Semi-Finished Composite Materials Market Report, History and Forecast 2019-2023, Breakdown Data by Manufacturers, Key Regions,...

Aerospace Industry Paint Spray Guns Market: Global Opportunities, Regional Overview, Top Leaders, Size, Revenue and Forecast up to 2025 – Jewish Life…

Posted on by

This report presents the worldwide Aerospace Industry Paint Spray Guns market size (value, production and consumption), splits the breakdown (data status 2018 and forecast to 2025), by manufacturers, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2697351&source=atm

The report provides a valuable source of insightful data for business strategists and competitive analysis of Aerospace Industry Paint Spray Guns Market. It provides the Aerospace Industry Paint Spray Guns industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Aerospace Industry Paint Spray Guns study provides comprehensive data which enhances the understanding, scope and application of this report.

Segment by Type, the Aerospace Industry Paint Spray Guns market is segmented intoManualAutomatic

Segment by Application, the Aerospace Industry Paint Spray Guns market is segmented intoAircraftGuided MissilesSpace VehiclesOthers

Regional and Country-level AnalysisThe Aerospace Industry Paint Spray Guns market is analysed and market size information is provided by regions (countries).The key regions covered in the Aerospace Industry Paint Spray Guns market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.Competitive Landscape and Aerospace Industry Paint Spray Guns Market Share Analysis

Aerospace Industry Paint Spray Guns market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Aerospace Industry Paint Spray Guns by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Aerospace Industry Paint Spray Guns business, the date to enter into the Aerospace Industry Paint Spray Guns market, Aerospace Industry Paint Spray Guns product introduction, recent developments, etc.The major vendors covered:ANEST-IWATAGRACOSAMES KREMLIN3MSataWagner

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2697351&source=atm

Regional Analysis For Aerospace Industry Paint Spray Guns Market:

For comprehensive understanding of market dynamics, the global Aerospace Industry Paint Spray Guns market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Influence of the Aerospace Industry Paint Spray Guns market report:

-Comprehensive assessment of all opportunities and risk in the Aerospace Industry Paint Spray Guns market.

Aerospace Industry Paint Spray Guns market recent innovations and major events.

-Detailed study of business strategies for growth of the Aerospace Industry Paint Spray Guns market-leading players.

-Conclusive study about the growth plot of Aerospace Industry Paint Spray Guns market for forthcoming years.

-In-depth understanding of Aerospace Industry Paint Spray Guns market-particular drivers, constraints and major micro markets.

-Favorable impression inside vital technological and market latest trends striking the Aerospace Industry Paint Spray Guns market.

The report has 150 tables and figures browse the report description and TOC:

Table of Contents of Aerospace Industry Paint Spray Guns Market

1 Study Coverage

1.1 Aerospace Industry Paint Spray Guns Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Aerospace Industry Paint Spray Guns Market Size Growth Rate by Type

1.4.2 Hydraulic Dredges

1.4.3 Hopper Dredges

1.4.4 Mechanical Dredges

1.5 Market by Application

1.5.1 Global Aerospace Industry Paint Spray Guns Market Size Growth Rate by Application

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2697351&licType=S&source=atm

2 Executive Summary

2.1 Global Aerospace Industry Paint Spray Guns Market Size

2.1.1 Global Aerospace Industry Paint Spray Guns Revenue 2014-2025

2.1.2 Global Aerospace Industry Paint Spray Guns Production 2014-2025

2.2 Aerospace Industry Paint Spray Guns Growth Rate (CAGR) 2019-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Aerospace Industry Paint Spray Guns Manufacturers

2.3.2.1 Aerospace Industry Paint Spray Guns Manufacturing Base Distribution, Headquarters

2.3.2.2 Manufacturers Aerospace Industry Paint Spray Guns Product Offered

2.3.2.3 Date of Manufacturers Enter into Aerospace Industry Paint Spray Guns Market

2.4 Key Trends for Aerospace Industry Paint Spray Guns Markets & Products

3 Market Size by Manufacturers

3.1 Aerospace Industry Paint Spray Guns Production by Manufacturers

3.1.1 Aerospace Industry Paint Spray Guns Production by Manufacturers

3.1.2 Aerospace Industry Paint Spray Guns Production Market Share by Manufacturers

3.2 Aerospace Industry Paint Spray Guns Revenue by Manufacturers

3.2.1 Aerospace Industry Paint Spray Guns Revenue by Manufacturers (2019-2025)

3.2.2 Aerospace Industry Paint Spray Guns Revenue Share by Manufacturers (2019-2025)

3.3 Aerospace Industry Paint Spray Guns Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

More Information.

Continued here:

Aerospace Industry Paint Spray Guns Market: Global Opportunities, Regional Overview, Top Leaders, Size, Revenue and Forecast up to 2025 - Jewish Life...

Aerospace Roller Bearings Market: Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecast to 2025 – 3rd Watch…

Posted on by

Global Aerospace Roller Bearings Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Aerospace Roller Bearings industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2720418&source=atm

For competitor segment, the report includes global key players of Aerospace Roller Bearings as well as some small players.

Segment by Type, the Aerospace Roller Bearings market is segmented intoStainless SteelFiber-reinforced CompositesEngineered PlasticsAluminum AlloysOthers

Segment by Application, the Aerospace Roller Bearings market is segmented intoLanding GearEngineFlight Control SystemAerostructureOthers

Regional and Country-level AnalysisThe Aerospace Roller Bearings market is analysed and market size information is provided by regions (countries).The key regions covered in the Aerospace Roller Bearings market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.Competitive Landscape and Aerospace Roller Bearings Market Share Analysis

Aerospace Roller Bearings market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Aerospace Roller Bearings by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Aerospace Roller Bearings business, the date to enter into the Aerospace Roller Bearings market, Aerospace Roller Bearings product introduction, recent developments, etc.The major vendors covered:Enpro Industries (GGB Bearings)National Precision BearingSKFJTEKTTimkenSchaeffler GroupRBC BearingsAurora BearingPacamor Kubar BearingsNSKAST BearingsNew Hampshire Ball BearingsNTNKamanRexnordRegal Beloit

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2720418&licType=S&source=atm

Important Key questions answered in Aerospace Roller Bearings market report:

What will the market growth rate, Overview, and Analysis by Type of Aerospace Roller Bearings in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Aerospace Roller Bearings market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of Aerospace Roller Bearings market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2720418&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Aerospace Roller Bearings product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Aerospace Roller Bearings , with price, sales, revenue and global market share of Aerospace Roller Bearings in 2019 and 2015.

Chapter 3, the Aerospace Roller Bearings competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Aerospace Roller Bearings breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, Aerospace Roller Bearings market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe Aerospace Roller Bearings sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Go here to see the original:

Aerospace Roller Bearings Market: Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecast to 2025 - 3rd Watch...

Trending Today Corona impact on Aerospace Used Serviceable Material Market Trend, Future Demand and Forecast till 2025 | ORBCOMM, INC., INMARSAT…

Posted on by

The global Aerospace Used Serviceable Material Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Aerospace Used Serviceable Material Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Aerospace Used Serviceable Material Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Aerospace Used Serviceable Material Market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Aerospace Used Serviceable Material Market.

Leading players of the global Aerospace Used Serviceable Material Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Aerospace Used Serviceable Material Market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Aerospace Used Serviceable Material Market. It also provides useful recommendations for new as well as established players of the global Aerospace Used Serviceable Material Market.

Final Aerospace Used Serviceable Material Report will add the analysis of the impact of COVID-19 on this Market.

Aerospace Used Serviceable Material Market competition by top manufacturers/Key player Profiled:Honeywell International Inc., GE Aviation, Eaton Corporation, Boeing, Raytheon Company, Deutsche Lufthansa AG, Liebherr Group, AAR Corp, A J Walter Aviation Limited, United Technologies Corporation, Safran SA, Curtiss Wright Corporation, Rolls-Royce plc, GA Telesis, LLC, Air France-KLM Group

>>> Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Aerospace Used Serviceable Material Market:

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Aerospace Used Serviceable Material Report by Material, Application, and Geography Global Forecast to 2023 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Aerospace Used Serviceable Material market is valued at USD XX million in 2020 and is projected to reach USD XX million by the end of 2024, growing at a CAGR of XX% during the period 2020 to 2024.

The report firstly introduced the Aerospace Used Serviceable Material basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Segmentation by Product:

General Type

Segmentation by Application:

Aircraft

Competitive Analysis:

Global Aerospace Used Serviceable Material Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Aerospace Used Serviceable Material Market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Scope of the Report:The all-encompassing research weighs up on various aspects including but not limited to important industry definition, product applications, and product types. The pro-active approach towards analysis of investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume and end-use offers more value to the overall statistics on the Aerospace Used Serviceable Material Market. All factors that help business owners identify the next leg for growth are presented through self-explanatory resources such as charts, tables, and graphic images.

The report offers in-depth assessment of the growth and other aspects of the Aerospace Used Serviceable Material market in important countries (regions), including:

North America(United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

For Customised Template PDF Report:https://www.reporthive.com/request_customization/2345567

Table of Contents

Report Overview:It includes major players of the global Aerospace Used Serviceable Material Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Aerospace Used Serviceable Material Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Aerospace Used Serviceable Material Market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Aerospace Used Serviceable Material Market by application, it gives a study on the consumption in the global Aerospace Used Serviceable Material Market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Aerospace Used Serviceable Material Market are profiled in this section. The analysts have provided information about their recent developments in the global Aerospace Used Serviceable Material Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Aerospace Used Serviceable Material Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Aerospace Used Serviceable Material Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Aerospace Used Serviceable Material Market.

Key Findings: This section gives a quick look at important findings of the research study.

About Us:Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Contact Us:

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.com

Email: [emailprotected]

Phone: +1 312-604-7084

Continue reading here:

Trending Today Corona impact on Aerospace Used Serviceable Material Market Trend, Future Demand and Forecast till 2025 | ORBCOMM, INC., INMARSAT...